Rigel Pharmaceuticals, Inc.
Rigel Pharmaceuticals,Inc.
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Rigel Pharmaceuticals, Inc. as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 06:44 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT02433236 · Open Label Study of Fostamatinib in the Treatment of IgA NephropathyRigel Pharmaceuticals · withdrawn · IGA Nephropathy · study director
- Ph2NCT02112838 · Safety and Efficacy Study of Fostamatinib to Treat Immunoglobin A (IgA) NephropathyRigel Pharmaceuticals · completed · IGA Nephropathy · study director
- Ph3NCT02077192 · Open Label Study of R788 in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura (ITP)Rigel Pharmaceuticals · completed · Immune Thrombocytopenic Purpura · study director
- Ph3NCT02076399 · A Efficacy and Safety Study of R935788 in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura (ITP)Rigel Pharmaceuticals · completed · Immune Thrombocytopenic Purpura · study director
- Ph3NCT02076412 · A Efficacy and Safety Study of Fostamatinib in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura (ITP)Rigel Pharmaceuticals · completed · Immune Thrombocytopenic Purpura · study director
- Ph2NCT02040623 · Safety and Efficacy Study of R932348 Ophthalmic Solution in Chronic Ocular Graft Versus Host Disease Patients(DROPS-2)Rigel Pharmaceuticals · completed · Chronic Graft-versus-host Disease · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 06:44 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.